Day & Night Nurse and Covonia among 20 cold and flu remedies pulled from UK shelves over "very rare" health risk

14 March 2023, 12:04 | Updated: 14 March 2023, 17:15

Day Nurse, Night Nurse and Covonia cold and flu remedies pulled from UK shelves over health fears
Day Nurse, Night Nurse and Covonia cold and flu remedies pulled from UK shelves over health fears. Picture: LBC / Alamy

By Danielle DeWolfe

Cold and flu remedies Day & Night Nurse capsules and Covonia are among 20 remedies pulled from UK shelves over "very rare" reactions, first flagged in Europe months ago.

The remedies - as well as own-brand version sold by pharmacies including Boots and Superdrug - have now been withdrawn from shelves "as a precaution" following a review by medical regulators.

The European Medicines Agency recommended their withdrawal three months ago, with the products' removal only taking place today.

Pholcodine is an opioid medicine found in a range of household cough syrups, with the immediate recall encompassing both syrups and lozenges across the UK.

The opioid is widely used in cold and flu products due to its ability to suppress coughing.

The review revealed the benefits of a drug named pholcodine, contained within the cough and cold medicines, "do not outweigh the increased risk of the very rare event of anaphylaxis".
The review revealed the benefits of a drug named pholcodine, contained within the cough and cold medicines, "do not outweigh the increased risk of the very rare event of anaphylaxis". Picture: LBC / Alamy

Regulators have now warned people to check the packaging of cough tablets and syrups at home to see if pholcodine is listed.

The review revealed the benefits of a drug named pholcodine, contained within the cough and cold medicines, "do not outweigh the increased risk of the very rare event of anaphylaxis".

The Medicines and Healthcare products Regulatory Agency (MHRA) polices the drug safety in Britain, however, the recall following a review has come three months after warnings were first raised across Europe.

Read more: Watch shocking moment woman smashes through wine bottles with frying pan in Tesco

Read more: Primary school teacher stabbed 'cheating' boyfriend to death and buried body in garden, court told

The MHRA flagged the evidence suggested an increased risk of anaphylaxis extended to "patients who receive general anaesthesia involving neuromuscular blocking agents during surgery".

PAGB Chief Executive, Michelle Riddalls, said: “We and our members put an absolute priority on patient safety. The risk in people who have used pholcodine is extremely small and the MHRA has taken this decision as a precaution.

“This precautionary measure is an example of the robust safety measures that we have in place in the UK working effectively.

“Our members are working very closely with MHRA, healthcare professionals and pharmacists to ensure that appropriate action is taken.

“Pholcodine containing products have only been available for purchase in pharmacies and if people have any questions pharmacists are well placed to give advice and recommend alternative products.”

Regulators have now warned people to check the packaging of cough tablets and syrups at home to see if pholcodine is listed.
Regulators have now warned people to check the packaging of cough tablets and syrups at home to see if pholcodine is listed. Picture: LBC / Alamy

Products containing Pholocodine are currently only available to purchase from UK pharmacies, as opposed to supermarket aisles.

The watchdog also pointed out there was "no increased risk" of allergic reactions with allergens other than specific neuromuscular blocking agents following the use of pholcodine.

"The absolute risk in patients who have used pholcodine is very small, but patients should talk to a pharmacist, their GP or their surgical team if they have any questions," the MHRA said.

“The Commission on Human Medicines (CHM), the independent advisory body that provides expert advice on the safety, quality and efficacy of medicines, has considered the evidence of an increased risk of the very rare event of anaphylaxis when exposed to neuromuscular blocking agents (NMBA) and advised that pholcodine-containing medicines should be withdrawn.”

The full list of products slated for recall are as follows:

The Boots Company PLC

  • Boots Night Cough Relief Oral Solution PL 00014/0230
  • Boots Dry Cough Syrup 6 Years+ PL 00014/0523
  • Boots Day Cold & Flu Relief Oral Solution PL 00014/0565

Thornton & Ross Limited

  • Cofsed Linctus PL 00240/0097
  • Care Pholcodine 5mg/5ml Oral Solution Sugar Free PL 00240/0101
  • Galenphol Paediatric Linctus PL 00240/0102
  • Galenphol Strong Linctus, PL 00240/0103
  • Covonia Dry Cough Sugar Free Formula PL 00240/0353

Bell Sons & Company (Druggists) Limited

  • Pholcodine Linctus Bells Healthcare 5mg Per 5ml Oral Solution PL 03105/0059
  • Numark Pholcodine 5mg per 5ml Oral Solution PL 03105/0059

Well Pharmaceuticals

  • Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059

Superdrug Pholcodine

  • Linctus BP PL 03105/0059
  • Strong Pholcodine Linctus BP PL 03105/0060

Pinewood Laboratories Limited

  • Pholcodine Linctus BP PL 04917/0002
  • Strong Pholcodine Linctus BP, PL 04917/0005

LCM Limited

  • Pholcodine Linctus PL 12965/0030

Glaxosmithkline Consumer Healthcare (UK) Trading Limited

  • Day & Night Nurse Capsules PL 44673/0068
  • Day Nurse Capsules PL 44673/0069
  • Day Nurse PL 44673/0075

Source: MHRA